The manufacturer of the diabetes drug Actos, a drug that is tied up in mounting complaints and lawsuits citing the development of bladder cancer, has received U.S. Food and Drug…
Carey Danis LoweFebruary 8, 2013
An Actos Multi-District Litigation (MDL) has been consolidated in Louisiana as of December 2011. The Actos MDL is being heard by U.S. District Judge Doherty in the U.S. District Court…
Carey Danis LoweJanuary 16, 2013
Actos is a drug developed by Takeda Pharmaceuticals, and is prescribed to patients with type 2 diabetes. The drug Actos has been closely linked with bladder cancer. Plaintiffs in Actos…
Carey Danis LoweJanuary 4, 2013
It has now come to light that Takeda Pharmaceuticals knew about the cancer risks associated with the ingestion of Actos, a drug they developed to treat type 2 diabetes. However,…
Carey Danis LoweDecember 12, 2012
Submit Your Claim The European Medicines Agency made an effort to provide more detail on its conclusion regarding the safety of drugs containing pioglitazone, including the diabetes drug Actos. The…
Carey Danis LoweDecember 6, 2012
Published November 29, 2012 by PR Web St. Louis, Missouri (PRWEB) November 29, 2012 November is American Diabetes Month and the pharmaceutical product liability lawyers at Carey Danis & Lowe…
Carey Danis LoweDecember 3, 2012
Research demonstrates a strong connection between the development of bladder cancer and the use of Actos, a drug prescribed to patients with diabetes. Actos is known generically as pioglitazone, and…
Carey Danis LoweNovember 26, 2012